Impact of Smoking and Smoking Cessation on Oncologic Outcomes in Primary Non-muscle-invasive Bladder Cancer

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F13%3A10209582" target="_blank" >RIV/00064203:_____/13:10209582 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11130/13:10209582
Result on the web
<a href="http://dx.doi.org/10.1016/j.eururo.2012.08.025" target="_blank" >http://dx.doi.org/10.1016/j.eururo.2012.08.025</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1016/j.eururo.2012.08.025" target="_blank" >10.1016/j.eururo.2012.08.025</a>

Result language
angličtina
Original language name
Impact of Smoking and Smoking Cessation on Oncologic Outcomes in Primary Non-muscle-invasive Bladder Cancer
Original language description
We collected smoking data from 2043 patients with primary NMIBC. Smoking variables included smoking status, average number of cigarettes smoked per day (CPD), duration in years, and time since smoking cessation. Lifetime cumulative smoking exposure was categorised as light short term ({= 19 CPD, {= 19.9 yr), light long term ({= 19 CPD, }= 20 yr), heavy short term (}= 20 CPD, {= 19.9 yr) and heavy long term (}= 20 CPD, }= 20 yr). The median follow-up in this retrospective study was 49 mo.
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—

Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2013
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)